K182565

Substantially Equivalent

AtriCure cryoICE cryoSPHERE cryoablation probe

Applicant: AtriCure, Inc.
Product code: GXH
Advisory panel: Neurology
Date received: 2018-09-18
Decision date: 2018-11-09
Decision: Substantially Equivalent
Clearance type: Special
Location: Mason, OH, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.